Advertisement
Decoding the JTO Impact Factor: A Comprehensive Guide
Introduction:
Are you grappling with the complexities of academic publishing and the elusive concept of the "JTO impact factor"? This comprehensive guide is designed to demystify this crucial metric, offering clarity and actionable insights for researchers, academics, and anyone seeking to understand the weight and influence of journals in the field of [Specify the field, e.g., Transportation Engineering, or specify if JTO refers to a specific journal – if not specified, general academic publishing is assumed]. We'll delve into what an impact factor truly means, how it's calculated, its limitations, and its implications for your research career. By the end of this post, you'll possess a solid understanding of JTO impact factor and its role in navigating the academic landscape.
What is the JTO Impact Factor (Assuming JTO is not a specific journal acronym)?
It's crucial to first clarify that "JTO" isn't a standard abbreviation used in academic publishing to denote a specific journal or database. Therefore, we'll interpret "JTO impact factor" as referring to the impact factor of a generic journal within a specific field. The impact factor is a metric used to assess the relative importance or influence of a scholarly journal within its field. It reflects the average number of citations received by articles published in that journal during a specific period (typically the past two years). A higher impact factor generally indicates a greater influence and visibility within the academic community.
How is the Journal Impact Factor Calculated?
The impact factor calculation, while seemingly simple, involves several steps. Leading citation indexing services like Clarivate Analytics' Web of Science (which publishes the Journal Citation Reports) use a specific methodology:
1. Citation Count: They count all citations made to articles published in a specific journal during a two-year period (e.g., 2021 and 2022 for the 2023 impact factor).
2. Citable Items: They identify the total number of citable items (typically articles, reviews, and letters) published in that journal during the same two-year period.
3. Calculation: The impact factor is then calculated by dividing the total number of citations by the total number of citable items.
Example: If a journal received 1000 citations for articles published in 2021 and 2022, and it published 250 citable items in those two years, its impact factor would be 1000/250 = 4.
Understanding the Limitations of the JTO Impact Factor (or any Journal Impact Factor):
While the impact factor is a widely used metric, it's critical to acknowledge its limitations:
Field Dependency: Impact factors vary greatly across different fields. A high impact factor in one field might not be comparable to a high impact factor in another. The nature of the research, the size of the field, and publication practices all influence citation rates.
Citation Bias: Certain types of research are more likely to be cited than others. Review articles, meta-analyses, and highly influential studies tend to receive more citations, potentially skewing the impact factor of journals that publish them frequently.
Gaming the System: There have been concerns about journals manipulating their impact factors through questionable practices, including self-citation or citation stacking.
Focus on Quantity over Quality: A high impact factor doesn't necessarily equate to high-quality research. It’s crucial to consider the rigor, originality, and significance of the research published within a journal, not just the citation count.
The Implications of JTO Impact Factor for Researchers:
The impact factor plays a significant role in various aspects of academic life:
Journal Selection: Researchers often consider the impact factor when choosing where to submit their manuscripts, aiming for journals with a higher impact factor to enhance the visibility and reach of their work.
Funding Applications: Funding agencies often use impact factor as one criterion for evaluating research proposals and researchers’ track records.
Career Advancement: Impact factor can influence promotions, tenure decisions, and other career advancements within academia.
Journal Ranking: Impact factor contributes to the overall ranking and reputation of academic journals.
Conclusion:
The JTO impact factor, or the impact factor of any journal, provides a snapshot of a journal's relative influence within its field. However, it’s crucial to interpret this metric cautiously, considering its limitations and avoiding a solely impact factor-driven approach to academic publishing and research evaluation. Focusing on the quality, originality, and impact of your research, rather than solely chasing a high impact factor journal, is a far more sustainable and meaningful strategy for a successful research career.
Article Outline: Decoding the JTO Impact Factor
Introduction: Defining the JTO impact factor (in the context of a general journal) and its significance.
Chapter 1: Understanding Impact Factor Calculation: Detailed explanation of the methodology used by citation indexing services.
Chapter 2: Limitations of the Impact Factor: Addressing the biases and potential flaws in relying solely on the impact factor.
Chapter 3: Implications for Researchers: Examining the impact factor's role in publication strategies, funding, and career advancement.
Chapter 4: Beyond the Impact Factor: Emphasizing the importance of quality research and responsible evaluation metrics.
Conclusion: Recap of key takeaways and a balanced perspective on the impact factor's usefulness.
(Detailed explanation of each point in the outline is provided above in the main article body.)
FAQs:
1. Is a high impact factor always indicative of high-quality research? No, a high impact factor doesn't guarantee high-quality research; it reflects citation frequency, not necessarily research quality.
2. How often is the impact factor calculated? Typically, the impact factor is calculated annually, based on citations received over the previous two years.
3. Can the impact factor of a journal change over time? Yes, the impact factor can fluctuate from year to year, reflecting changes in the journal's publication and citation patterns.
4. What are some alternative metrics for assessing journal quality? Altmetrics (alternative metrics) such as social media shares, downloads, and mentions in news outlets provide additional insights into research impact.
5. Should researchers solely focus on publishing in high impact factor journals? No, prioritizing research quality and selecting a journal that is the best fit for the research is more important than chasing a high impact factor.
6. How can I find the impact factor of a specific journal? Major citation indexing services like Web of Science and Scopus provide impact factor data for journals they index.
7. What is self-citation, and why is it problematic? Self-citation is when authors cite their own previous work excessively, artificially inflating the impact factor of a journal.
8. Does a low impact factor mean the journal is of poor quality? Not necessarily. Some journals in niche or emerging fields may have lower impact factors despite publishing high-quality research.
9. How can I use the impact factor information strategically in my research career? Use the impact factor as one factor among many when choosing a journal for submission, focusing primarily on the journal's relevance to your research and its editorial standards.
Related Articles:
1. Altmetrics vs. Impact Factor: A Comparative Analysis: Examines the differences and strengths of traditional impact factors versus alternative metrics for assessing research impact.
2. The Ethics of Journal Impact Factors: Discusses concerns regarding the manipulation of impact factors and the ethical implications of using them as the primary evaluation metric.
3. Journal Selection Strategies for Early Career Researchers: Provides practical advice for early-career researchers on selecting appropriate journals for their research.
4. Understanding Citation Analysis in Academic Publishing: Explores the broader context of citation analysis and its role in evaluating scholarly work.
5. The Role of Impact Factors in Research Funding Decisions: Analyzes how funding agencies use impact factors in their evaluation processes.
6. Open Access Publishing and Impact Factors: Examines the relationship between open access publishing and journal impact factors.
7. Impact Factor and Journal Rankings: A Critical Review: Critically evaluates the use of impact factors in journal rankings and their influence on academic publishing.
8. How to Improve Your Chances of Publication in High-Impact Journals: Provides practical tips for increasing the likelihood of getting your research published in prestigious journals.
9. Navigating the Academic Publication Landscape: A Practical Guide: Offers comprehensive guidance on all aspects of academic publishing, including manuscript preparation and journal selection.
| jto impact factor: Who Classification of Tumours of the Lung, Pleura, Thymus and Heart International Agency for Research on Cancer, 2015-03-16 WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart is the seventh volume in the Fourth Edition of the WHO series on histological and genetic typing of human tumors. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. |
| jto impact factor: Stereotactic Body Radiation Therapy Simon S. Lo, Bin S. Teh, Jiade J. Lu, Tracey E. Schefter, 2012-08-28 Stereotactic body radiation therapy (SBRT) has emerged as an important innovative treatment for various primary and metastatic cancers. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists. |
| jto impact factor: Thoracic Tumours W. H. O. Classification WHO Classification of Tumours Editorial Board, 2021-04-21 ****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Thoracic Tumoursis the fifth available volume in the fifth edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The fifth edition, guided by the WHO Classification of Tumours Editorial Board, establishes a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? * Pathologists * Oncologists * Respiratory physicians * Thoracic radiologists * Cancer researchers * Surgeons * Epidemiologists * Cancer registrars This volume: * Prepared by 217 authors and editors * Contributors from around the world * More than 1000 high-quality images * More than 3500 references |
| jto impact factor: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Practical Approach S.E. Monaco, W.E. Khalbuss, L. Pantanowitz, 2014-05-22 This high-yield reference book focuses on the clinical, technical, and pathological aspects of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Its reviews cover all aspects of EBUS-TBNA, including the clinical perspective, technical aspects of the procedure, and cytomorphology of common and uncommon entities, as well as highlights diagnostic challenges. Each chapter features a multitude of full-color high-resolution images and includes key references to the current literature in the field. Additionally, reference tables and informative figures highlight the salient points. The book is unique in that it is written by experienced thoracic surgeons, pulmonary medicine physicians, and cytopathologists who use EBUS-TBNA in a large medical center. This publication is of interest to individuals learning and practicing cytopathology, in addition to clinicians practicing pulmonary/thoracic medicine or surgery. In short, it provides important pearls of wisdom to create a comprehensive reference for all physicians involved with EBUS-TBNA. |
| jto impact factor: Cancer Survival and Prevalence in Australia Australian Institute of Health and Welfare, 2012 This report presents the latest national survival and prevalence statistics for cancers in Australia from 1982 to 2010. Survival from cancer is a key indicator of cancer prognosis, control and treatment. It refers to the probability of being alive for a given amount of time after diagnosis and reflects the severity of a cancer diagnosis. |
| jto impact factor: Thoracic Malignancies Steven E. Schild, MD, 2010-03-08 Thoracic Malignancies: Thoracic Malignancies is the first title in Radiation Medicine Rounds. These tumors take more lives than any others and they are among the most preventable of tumors. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management. Thoracic Malignancies addresses the multi-disciplinary nature of the care of these tumors. There is representation from radiation oncology, medical oncology, and surgery ensuring a well-rounded summarization of current practice. Included are chapters on lung cancer, esophageal cancer, and thymomas providing coverage of the vast majority of thoracic tumors. The multi-disciplinary nature of the articles provides readers with an up-to-date summary and a well-rounded review regarding these tumors and their care. Expert authors provide reviews and assessments of the most recent data and its implications for current clinical practice, along with insights into emerging new trends of importance for the near future. About the Series Radiation Medicine Rounds is an invited review publication providing a thorough analysis of new scientific, technologic, and clinical advances in all areas of radiation medicine. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Radiation Medicine Rounds provides authoritative, thorough assessments of a wide range of Ïhot topicsÓ and emerging new data for the entire specialty of radiation medicine. Features of Radiation Medicine Rounds include: Editorial board of nationally recognized experts across the spectrum of radiation medicine In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine Issues edited by an authority in specific subject area Focuses on major topics in Radiation Medicine with in-depth articles covering advances in radiation science radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcomes studies Emphasizes multidisciplinary approaches to research and practice |
| jto impact factor: The Elements of Style William Strunk Jr., 2023-10-01 First published in 1918, William Strunk Jr.'s The Elements of Style is a guide to writing in American English. The boolk outlines eight elementary rules of usage, ten elementary principles of composition, a few matters of form, a list of 49 words and expressions commonly misused, and a list of 57 words often misspelled. A later edition, enhanced by E B White, was named by Time magazine in 2011 as one of the 100 best and most influential books written in English since 1923. |
| jto impact factor: IASLC Staging Handbook in Thoracic Oncology Ramon Rami-Porta, 2016-12-04 |
| jto impact factor: Soviet Physics , 1983 |
| jto impact factor: Light and Photosynthesis in Aquatic Ecosystems John T. O. Kirk, 2010-12-23 Beginning systematically with the fundamentals, the fully-updated third edition of this popular graduate textbook provides an understanding of all the essential elements of marine optics. It explains the key role of light as a major factor in determining the operation and biological composition of aquatic ecosystems, and its scope ranges from the physics of light transmission within water, through the biochemistry and physiology of aquatic photosynthesis, to the ecological relationships that depend on the underwater light climate. This book also provides a valuable introduction to the remote sensing of the ocean from space, which is now recognized to be of great environmental significance due to its direct relevance to global warming. An important resource for graduate courses on marine optics, aquatic photosynthesis, or ocean remote sensing; and for aquatic scientists, both oceanographers and limnologists. |
| jto impact factor: Molecular Pathology of Lung Cancer Philip T. Cagle, Timothy Craig Allen, Mary Beth Beasley, Lucian R. Chirieac, Sanja Dacic, Alain C. Borczuk, Keith M. Kerr, 2012-06-14 As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff. |
| jto impact factor: Experimentation with Human Subjects Paul Abraham Freund, 1970 Most of the essays appeared in the spring 1969 issue of Dædalus. |
| jto impact factor: Lung Cancer and Personalized Medicine Aamir Ahmad, Shirish Gadgeel, 2015-12-14 This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer—immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies. |
| jto impact factor: Lung Cancer: A Practical Approach to Evidence-Based Clinical Evaluation and Management Lynn T. Tanoue, Frank C Detterbeck, 2018-05-30 Get a quick, expert overview of the many key facets of lung cancer evaluation and management with this concise, practical resource by Drs. Lynn T. Tanoue and Frank Detterbeck. This easy-to-read reference presents a summary of today's best evidence-based approaches to diagnosis and management in this critical area. - Covers diagnosis and evaluation, treatment considerations, and comprehensive care options for patients with lung cancer. - Provides insight on evidence for today's best practices, as well as future directions in the field. - Consolidates today's evidence-based information on the clinical aspects of lung cancer into one convenient resource. |
| jto impact factor: The American Cancer Society's Oncology in Practice The American Cancer Society, 2018-05-01 Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of clinical management for cancer taking a balanced, authoritative and, -where possible- evidence-based stance and may be used in conjunction with the book, The American Cancer Society's Principles of Oncology: Prevention to Survivorship. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a practical understanding of the field of oncology. |
| jto impact factor: Tumors of the Thymus Juan Rosai, Gerald D. Levine, 1976 |
| jto impact factor: Advances in Radiation Oncology Jeffrey Y.C. Wong, Timothy E. Schultheiss, Eric H. Radany, 2017-04-20 This book concisely reviews important advances in radiation oncology, providing practicing radiation oncologists with a fundamental understanding of each topic and an appreciation of its significance for the future of radiation oncology. It explores in detail the impact of newer imaging modalities, such as multiparametric magnetic resonance imaging (MRI) and positron emission tomography (PET) using fluorodeoxyglucose (FDG) and other novel agents, which deliver improved visualization of the physiologic and phenotypic features of a given cancer, helping oncologists to provide more targeted radiotherapy and assess the response. Due consideration is also given to how advanced technologies for radiation therapy delivery have created new treatment options for patients with localized and metastatic disease, highlighting the increasingly important role of image-guided radiotherapy in treating systemic and oligometastatic disease. Further topics include the potential value of radiotherapy in enhancing immunotherapy thanks to the broader immune-stimulatory effects, how cancer stem cells and the tumor microenvironment influence response, and the application of mathematical and systems biology methods to radiotherapy. |
| jto impact factor: Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Institute of Medicine, Board on the Health of Select Populations, Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2015-03-16 Myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) are serious, debilitating conditions that affect millions of people in the United States and around the world. ME/CFS can cause significant impairment and disability. Despite substantial efforts by researchers to better understand ME/CFS, there is no known cause or effective treatment. Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made. Some health care providers have been skeptical about the serious physiological - rather than psychological - nature of the illness. Once diagnosed, patients often complain of receiving hostility from their health care provider as well as being subjected to treatment strategies that exacerbate their symptoms. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS and a new term for the illness - systemic exertion intolerance disease(SEID). According to this report, the term myalgic encephalomyelitis does not accurately describe this illness, and the term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome stresses that SEID is a medical - not a psychiatric or psychological - illness. This report lists the major symptoms of SEID and recommends a diagnostic process.One of the report's most important conclusions is that a thorough history, physical examination, and targeted work-up are necessary and often sufficient for diagnosis. The new criteria will allow a large percentage of undiagnosed patients to receive an accurate diagnosis and appropriate care. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be a valuable resource to promote the prompt diagnosis of patients with this complex, multisystem, and often devastating disorder; enhance public understanding; and provide a firm foundation for future improvements in diagnosis and treatment. |
| jto impact factor: Histological Typing of Tumours of the Thymus Juan Rosai, 2012-12-06 This classification represents a project aimed at bringing together the variety of ways thymic epithelial neoplasms have been classified. It focuses on their growth characteristics, and cytoarchitectural features . The classification, though restricted to the thymic region rather than the mediastinum in general, also covers neuroendocrine, germ cell, lymphoid, and stromal tumours, as well as tumour-like lesions and the neck tumours of thymic or related branchial pouch derivation. |
| jto impact factor: Exercise Oncology Kathryn H. Schmitz, 2020-05-04 This groundbreaking book presents a unique and practical approach to the evolving field of exercise oncology - the study of physical activity in the context of cancer prevention and control. Presenting the current state of the art, the book is sensibly divided into four thematic sections. Following an opening chapter presenting an overview and timeline of exercise oncology, the chapters comprising part I discuss primary cancer prevention, physical activity and survivorship, and the mechanisms by which these operate. Diagnosis and treatment considerations are discussed in part II, including prehabilitation, exercise during surgical recovery, infusion and radiation therapies, and treatment efficacy. Post-treatment and end-of-life care are covered in part III, including cardio-oncology, energetics and palliative care. Part IV presents behavioral, logistical and policy-making considerations, highlighting a multidisciplinary approach to exercise oncology as well as practical matters such as reimbursement and economics. Written and edited by experts in the field, Exercise Oncology will be a go-to practical resource for sports medicine clinicians, family and primary care physicians, oncologists, physical therapy and rehabilitation specialists, and all medical professionals who treat cancer patients. |
| jto impact factor: French's Index of Differential Diagnosis An A-Z 1 Mark T. Kinirons, Harold Ellis, 2016-03-30 First published in 1912, French's Index of Differential Diagnosis helps clinicians in the differential diagnosis of any condition which may be seen in hospital or general practice. Arranged alphabetically by symptom, the text helps readers identify each presentation, describes the different diagnoses that it could represent, and explains the tests |
| jto impact factor: Advanced Therapy in Thoracic Surgery Kenneth L. Franco, Joe Billy Putnam, 2005 Summarizes many of the advances made in this area and reviews in depth the topics and treatment techniques not widely used in daily practice. New chapters to this second edition include: New Techniques to Manage Pain; Advances in Diagnostic Imaging; Management of Germ Cell Tumors of the Mediastinum, Updates on Diaphragmatic Pacing; and Preoperative Evaluation of Neuro-Motor Diseases of the Esophagus. |
| jto impact factor: Pathy's Principles and Practice of Geriatric Medicine Alan J. Sinclair, John E. Morley, Bruno Vellas, 2012-03-13 This new edition of the comprehensive and renowned textbook Principles and Practice of Geriatric Medicine offers a fully revised and updated review of geriatric medicine. It covers the full spectrum of the subject, features 41 new chapters, and provides up-to-date, evidence-based, and practical information about the varied medical problems of ageing citizens. The three editors, from UK, USA and France, have ensured that updated chapters provide a global perspective of geriatric medicine, as well as reflect the changes in treatment options and medical conditions which have emerged since publication of the 4th edition in 2006. The book includes expanded sections on acute stroke, dementia, cardiovascular disease, and respiratory diseases, and features a new section on end-of-life care. In the tradition of previous editions, this all-encompassing text continues to be a must-have text for all clinicians who deal with older people, particularly geriatric medical specialists, gerontologists, researchers, and general practitioners. This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from Google Play or the MedHand Store. Praise for the 4th edition: ...an excellent reference for learners at all clinical and preclinical levels and a useful contribution to the geriatric medical literature. —Journal of the American Medical Association, November 2006 5th edition selected for 2012 Edition of Doody's Core TitlesTM |
| jto impact factor: Tumors of the Lower Respiratory Tract Thomas V. Colby, Michael N. Koss, William D. Travis, Universities Associated for Research and Education in Pathology, 1995 |
| jto impact factor: Vedic Mathematics Or Sixteen Simple Mathematical Formulae from the Vedas for One-line Answers to All the Mathematical Problems) Bhāratī Kṛṣṇa Tīrtha, 1981 |
| jto impact factor: Tumor Organoids Shay Soker, Aleksander Skardal, 2017-10-20 Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell–cell, cell–ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies. |
| jto impact factor: TNM Supplement Christian Wittekind, James D. Brierley, Anne Lee, Elizabeth Van Eycken, 2019-07-12 The Union for International Cancer Controls (UICC) TNM classification system is the most widely used cancer classification and staging system in the world. It is used to describe the anatomical extent of disease and it is essential to patient care, research and cancer control. This fifth edition of the TNM Supplement: A Commentary of Uniform Use offers practitioners a wealth of material intended to complement the systems day-to-day use. The volume features: Updated definitions of terms used in cancer staging. New sections on carcinomas of the thymus, sarcomas of the spine and pelvis and soft tissue sarcomas of the head and neck, and comprehensive updates to the head and neck carcinomas, carcinomas of the lung and neuroendocrine tumours sections. Frequently asked questions from the UICC helpdesk. The Supplement may be treated as a companion text to the recent eighth edition of the TNM Classification of Malignant Tumours (978-1-119-26357-9), supporting the correct and uniform application of the TNM classification system. The TNM Supplement can also be utilised as a standalone book, providing explanations and examples to answer many questions that arise during the daily use of the TNM cancer classification and staging system, particularly in unusual cases. |
| jto impact factor: The State of Knowledge on Medical Assistance in Dying Where a Mental Disorder Is the Sole Underlying Medical Condition The Expert Panel Working Group on MAID Where a Mental Disorder Is the Sole Underlying Medical Condition, 2018-12-12 In December 2016, the CCA was asked by then Minister of Health Jane Philpott and Minister of Justice and Attorney General of Canada Jody Wilson-Raybould to undertake independent reviews related to medical assistance in dying (MAID). Specifically, the CCA was tasked with examining three particularly complex types of requests for MAID that were identified for further review and study in the legislation passed by Parliament in 2016: requests by mature minors, advance requests, and requests where a mental disorder is the sole underlying medical condition. On December 12, 2018 the CCA released the three final reports of the Expert Panel, one on each type of request: The State of Knowledge on Medical Assistance in Dying for Mature Minors; The State of Knowledge on Advance Requests for Medical Assistance in Dying; and The State of Knowledge on Medical Assistance in Dying Where a Mental Disorder is the Sole Underlying Medical Condition. |
| jto impact factor: Tobacco Control in China Gonghuan Yang, 2018-05-21 This book comprehensively covers the science and policy issues relevant to one of the major public health issues in China. It pulls together the prevalence pattern of tobacco use in different population and burden of the myriad of tobacco-related diseases. The book pays more attention to review the successes and failures of tobacco control policies in China, including the protect peoples from second-hand smoke, comprehensive banning tobacco advertisement promotion and sponsor, regulation of the contents of tobacco products and low tar cigarettes, warn about the dangers of tobacco, support for smokers to quit, and increasing tobacco taxation and price, as well as monitor and assessment on tobacco use and implement of prevention policy under the international background of tobacco control. The book analyse and explain the influence factors, especially interference from tobacco industry with public management theory frame for promoting tobacco control policies and looks at lessons learnt to help set health policy for reducing the burden of tobacco-related diseases. It is a helpful reference for experts in public health and epidemiologists in tobacco control, advocators and policy maker. |
| jto impact factor: Smoking and Health United States. Surgeon General's Advisory Committee on Smoking and Health, 1964 |
| jto impact factor: Blueprints Medicine William A. Kormos, Davoren A. Chick, 2010 One of the best selling and most highly regarded volumes in the Blueprints series, Blueprints Medicine provides a concise review of what students need to know in their rotations or the Boards. Each chapter is brief and includes pedagogical features such as bolded key words, tables, figures, and key points boxes. This edition has been reorganized to follow the Clerkship Directors in Internal Medicine guidelines and includes thoroughly updated content and additional tables and figures. A question-and-answer section at the end of the book includes 100 board-format questions with complete rationales for each answer choice. A companion website includes a question bank with 50 additional questions and answers and fully searchable text. |
| jto impact factor: Real-World Evidence in Lung Cancer Alfredo Addeo, Giuseppe Luigi Banna, Joshua Michael Bauml, Massimo Di Maio, 2021-09-24 |
| jto impact factor: Dermatologic Principles and Practice in Oncology Mario E. Lacouture, 2013-11-26 The first book focusing specifically on frequent and frequently disabling side effects involving the skin, hair and nails in cancer patients According to the World Health Organization, there are approximately thirty million people living with a diagnosis of cancer – the majority of whom will receive surgery, systemic therapy, and/or radiation, and who will suffer from dermatologic adverse events. Dermatologists and oncologists are only beginning to grapple with these events, which pose serious quality-of-life issues with so many patients, and will become more prevalent as survival rates improve, thanks in part to new cancer treatments and drug regimens. Concentrating on a topic that has only been briefly touched upon by other texts, this book offers a focused perspective on the clinical presentation, underlying pathophysiologic mechanisms, and management of skin, hair, and nail conditions for oncologists, dermatologists, and allied practitioners. Dermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair, and Nails in Cancer Patients: • Covers in detail the dermatologic adverse events of oncologic therapies, clinical presentations, and treatment recommendations • Enables dermatologists and other practitioners to significantly improve the care of patients with cancer • Addresses the dermatologic adverse events of cancer therapies used globally, of which a large number are found in developing countries • Emphasizes prophylactic measures – based on treatments used and type of cancer – to prevent the appearance of adverse events • Provides built-in discussions on patient education for practical counseling during therapies • Offers rapid-reference sections on topical dermatology drugs The first book to present dermatologic conditions in cancer patients and survivors in a uniform and in-depth manner, Dermatologic Principles and Practice in Oncology is ideal for oncologists, oncology nurses, and dermatologists who wish to take better care of those with adverse skin, hair, and nail conditions. |
| jto impact factor: Inventory of Water Resources Research in Australia , 1977 |
| jto impact factor: Breakthrough in Imaging-Guided Precision Medicine in Oncology Laurent Dercle, Samy Ammari, Florent L. Besson, Fatima-Zohra Mokrane, Romain-David Seban, Randy Yeh, 2022-03-11 |
| jto impact factor: Oncologic Critical Care Joseph L. Nates, Kristen J. Price, 2019-10-30 This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care. Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients. |
| jto impact factor: SEER, Surveillance, Epidemiology, and End Results Program SEER Program (National Cancer Institute (U.S.)), 2000 |
| jto impact factor: IASLC Atlas of ALK and ROS1 Testing in Lung Cancer Ming Sound Tsao, Fred R. Hirsch, Yasushi Yatabe, 2016-12-04 The IASLC Atlas of ALK and ROS1 Testing in Lung Cancer is a resource designed to help pathologists, laboratory scientists, and practicing physicians better understand the background, protocol, and interpretation of results of ALK and ROS1 testing for patients with advanced non-small cell lung cancer. |
| jto impact factor: Epidemiology of Lung Cancer Jonathan M. Samet, 1994-03-08 Providing a historical perspective on the etiology of lung cancer, this comprehensive reference presents an in-depth analysis of the epidemiology of cancer of the lung-describing the current understanding of risk factors and the use of epidemiological data to design programs for the control of this leading cause of death worldwide. |
| jto impact factor: International Manual of Oncology Practice Ramon Andrade De Mello, Giannis Mountzios, Álvaro A. Tavares, 2020-10-30 Cancer is a very aggressive disease and currently it has been considered a challenge to oncologists and cancer patients worldwide. Nowadays, several therapeutic strategies had improved toward last decades. Surgery is many times still the best curative treatment, mainly in early stage disease. However, Radiotherapy and chemotherapy acquired a main role in this scenario. Target therapies were introduced for medical oncology practice and are demonstrating a hallmark of a new era in cancer treatment. More recently, immunotherapy has been considered the novel cornerstone in cancer treatment. The 2nd edition of the International Manual of Oncology Practice (iMOP) emerged after the great success of the iMOP 1st edition as a reference for medical oncologists and medical residents in the field. In this edition, several chapters were revised and its addresses from the molecular issues of cancer sciences to the clinical practice in medical oncology. In addition, multiple choice questions and clinical cases were included in the main chapters in order to improve the reader learning. The book focuses systemic treatments in many areas of medical oncology, such as breast cancer, gastrointestinal, thoracic, urological oncology, head and neck tumors, bone tumors, sarcomas and palliative care. The topics herein discussed will provide the readers a step forward in the medical oncology practice understanding and give facilities for help in cancer patient treatments. |
